Partial response to Zercepac® plus chemotherapy in triple-positive advanced breast cancer with changed molecular typing
Minerva Med
.
2022 Jul 5.
doi: 10.23736/S0026-4806.22.08243-X.
Online ahead of print.
Authors
Fenge Jiang
1
,
Junxia Li
1
,
Congcong Wang
1
,
Ming Li
1
,
Yu Cao
1
,
Ping Sun
1
,
Jiannan Liu
2
Affiliations
1
The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong Province, P.R. China.
2
The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong Province, P.R. China - Liujiannansun2013@163.com.
PMID:
35785954
DOI:
10.23736/S0026-4806.22.08243-X
No abstract available